April 16, 2025

Newer Glucose-Lowering Drugs Reduce CV Events in Older Adults

"Use of GLP1-RAs and SGLT-2is was associated with reduced rates of 3P-MACE and HHF compared to DPP-4is, independent of age" - findings from a Danish nationwide study of 35,679 patients aged 70 and older with T2D.

Conexiant

April 16, 2025

CONSORT 2025: Setting New Standards for Clinical Trial Reporting

"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.

Conexiant

April 15, 2025

Mavacamten Misses Endpoints in nHCM Trial

Mavacamten's phase III trial for nonobstructive hypertrophic cardiomyopathy does not show significant improvement in functional capacity or symptoms, reflecting challenges in less severe populations. Bristol Myers Squibb plans to present full data at a future scientific meeting.

Reuters

April 11, 2025

Relaxation Techniques Lower Blood Pressure in Short Term, Study

Most relaxation interventions were associated with short-term reductions in blood pressure among adults with hypertension, according to a network meta-analysis of 182 randomized trials.

Conexiant

April 10, 2025

Morning Coffee Consumption Linked to Lower Mortality Risk

“Drinking coffee in the morning may be more strongly associated with a lower risk of mortality than drinking coffee later in the day."

Conexiant

April 09, 2025

Cessation of Alcohol Affects Lipid Profiles, Study

Monitoring lipid profiles after alcohol cessation are essential for optimizing cardiovascular disease risk management.

Conexiant

April 04, 2025

Warning Signs Before Sudden Cardiac Death

New research identified key clinical indicators that precede sudden arrhythmic death syndrome in patients under 36.

Conexiant

April 03, 2025

Oophorectomy May Elevate Heart Failure Risk

Bilateral ovary removal may increase heart failure risk 1.5-fold, with White women and younger patients facing double the risk, according to new research presented at ACC.25.

Conexiant

April 01, 2025

FDA Monthly Round-Up: Key March Updates

March’s FDA approvals feature new biosimilars, first-in-class therapies, expanded indications, and diagnostic innovations across allergy, cardiology, gastroenterology, infectious diseases, and more.

Conexiant